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The mammalian virome includes diverse commensal and pathogenic viruses that evoke a broad range of
immune responses from the host. Sustained viral immunomodulation is implicated in a variety of inflamma-
tory diseases, but also confers unexpected benefits to the host. These outcomes of viral infections are often
dependent on host genotype. Moreover, it is becoming clear that the virome is part of a dynamic network of
microorganisms that inhabit the body. Therefore, viruses can be viewed as a component of the microbiome,
and interactions with commensal bacteria and other microbial agents influence their behavior. This piece is a
review of our current understanding of how the virome, together with other components of the microbiome,
affects the function of the host immune system to regulate health and disease.Introduction
The collection of organisms inhabiting the human body, the mi-
crobiome, is an integral component of our physiology. In partic-
ular, the bacterial members of the microbiome are proposed to
mediate phenotypic differences between individuals, much like
gene variants in the host genome (Cho and Blaser, 2012). These
symbiotic bacteria are in a position to have an influential impact
on our biology because they are numerous, diverse, differ
between individuals, and interact with the host and each other
over a long period of time (Hooper and Gordon, 2001). These
qualities also describe the collection of viruses that inhabit our
body, and thus the virome is in a similar position as the bacterial
microbiome to impact human health and disease.
By any criterion, the size and diversity of the virome is stag-
gering. The mammalian virome includes viruses that infect cells
of the animal host, endogenous viral elements, and viruses that
infect members of the microbiome, most notably phages that
replicate in bacteria (Virgin, 2014). All adult humans are chroni-
cally infected withmultiple RNA and DNA animal viruses, ranging
from traditional pathogens to those that usually are innocuous
but are harmful in a small fraction of the population (Virgin
et al., 2009). Viruses that fall into the categories of commensal
and opportunistic pathogen include many that are detected in
the majority of the adult human population, such as members
of the herpesvirus, polyomavirus, adenovirus, circovirus, and
anellovirus families (Bernardin et al., 2010; Garnett et al., 2002;
Virgin et al., 2009; Wylie et al., 2014). Tragically, there are also
millions of individuals chronically infected with viruses associ-
ated with high rates of morbidity and mortality such as HIV,
hepatitis C virus (HCV), and hepatitis B virus (HBV) (Matthews
et al., 2014). By establishing long-term infections, these diverse
pathogenic and non-pathogenic animal viruses can be viewed
as ‘‘contributing’’ to the host phenotype, and the presence of a
subset might occasionally be beneficial.
The gastrointestinal tract in particular is a hotbed for transking-
dom interactions due to the apposition of the mucosal immune
system with viruses and microorganisms representing different
kingdoms of life. The number of viral particles in human feces
is in the same range as bacteria—upward of 109 per gram (Kim
et al., 2011a). Most of these viral particles correspond to phageswith extreme inter-individual variation, even when comparing
first-degree relatives (Minot et al., 2011; Reyes et al., 2010). It
is also clear that humans and other mammals harbor novel
animal viruses in the intestine that remain to be characterized
(Finkbeiner et al., 2008; Firth et al., 2014; Handley et al., 2012;
Phan et al., 2011). Metagenomics studies of the intestine and
other anatomical sites will continue to detect new sequences
corresponding to viruses, including those that currently elude
annotation.
In this review, recent findings indicating that the impact of
the mammalian virome matches the extraordinary diversity of
viruses that inhabit the bodywill be discussed. The immunomod-
ulatory effect of viruses will be emphasized, especially those that
have long-lasting consequences. There is also an emerging
paradigm that viruses functionally interact with one another or
other members of the microbiome to shape host immunity. Our
current understanding of how these complex transkingdom
interactions affect the host will be evaluated.
Immunomodulation by the Virome
Viral DNA and RNA trigger the production of interferons and
other cytokines upon recognition by innate immune sensors.
This initial response contributes to additional antiviral gene
expression, antibody-mediated neutralization, and killing of
virally infected cells by natural killer (NK) cells and cytotoxic
T lymphocytes (CTLs) (Takeuchi and Akira, 2009). To prevent
an unrestricted antiviral immune response from causing
excessive damage to the host, these classic antiviral effectors
are coupled with production of immunosuppressive cytokines
such as interleukin-10 (IL-10), regulatory T (Treg) cell activity,
and upregulation of inhibitory receptors on effector T cells
(Rouse and Sehrawat, 2010).
The objective of generating these soluble factors and mobi-
lizing cells is to combat the virus with as little cost to the host
as possible. However, induction of these effector and suppres-
sor mechanisms also modifies the state of immunity, referred
to herein as immunomodulation. Viral immunomodulation has
consequences for the host beyond antiviral defense and
can alter susceptibility to complex diseases and secondary
infections. Immunomodulation in its simplest form is dividedImmunity 42, May 19, 2015 ª2015 Elsevier Inc. 805
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Figure 1. Categories of Viral Immunomodulation
The presence of a virus can shift the qualitative and quantitative state of im-
munity in multiple dimensions, thereby altering susceptibility to inflammatory
diseases or subsequent infections.
(A) During immunopotentiation, a virus increases the magnitude of a subse-
quent response or decreases the threshold necessary to evoke a certain
immune response. In contrast, immunosuppression occurs when the immune
system is compromised and the magnitude of subsequent responses is
diminished.
(B) In addition to magnitude, the nature of subsequent immune responses can
be altered by previous viral infections. In the example shown, the presence of a
virus shifts the state of immunity toward a more potent Th1 cell response.
Another common outcome is sustained increase in type I interferon levels.
(C) Viral immunomodulation can change over time, occasionally returning
to basal levels, but often not all the way back to the original point. Other
dimensions of immunity that are subject to viral immunomodulation include
anatomical site and T cell receptor and B cell receptor repertoires.
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ing states of increased and decreased immunity, respectively
(Figure 1A). In addition to shifting the magnitude of responses,
viral immunomodulation can change the nature of immune
reactions generated by the host, such as T helper (Th) cell polar-
ization (Figure 1B). Although viral infections traditionally skew
immunity toward Th1 cell, respiratory syncytial virus (RSV) can
induce Th2 cell polarization in the lung (Culley et al., 2006).
Also, preferential targeting of Th17 cells by HIV indicates that
immunosuppression can have qualitative aspects as well (Pre-
ndergast et al., 2010). Immunomodulation can be local or sys-
temic, change over time, alter the immunogenicity of antigens,
and differ between anatomical compartments (Figure 1C).
Potentiation of one branch of the immune system might come
at the cost of another, and viral immunosuppression is often,
if not always, accompanied by a heightened state of inflamma-
tion. Therefore, viral immunomodulation is complex and multi-
dimensional.
Chronic infections are likely to delay or prolong immunomodu-
lation. Many viruses establish latency, a state in which the viral
genome persists within a cell without producing infectious viral
particles. During latency, the virus is less visible due to
decreased metabolic activity and amount of antigens available
for detection by receptors of the innate and adaptive immune
system. Viruses that display continuous replication employ other
strategies to persist. HBV evokes an unusually low innate im-
mune response by inhibitingmultiple steps of the type I interferon
(IFN-I) induction and signaling pathway, which probably allows
this virus to reside in the liver over the lifetime of the infected
individual (Busca and Kumar, 2014). Lymphocytic choriomenen-
gitis virus (LCMV) and murine norovirus (MNV) strains that
establish persistent infections in mice evoke suboptimal T cell
responses compared with acute strains that are successfully
eradicated (Tomov et al., 2013; Zajac et al., 1998). Cells
harboring latent or actively replicating viruses are not necessarily806 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.restricted to a particular anatomical location. Viruses often infect
cells of hematopoietic origin that circulate through the blood and
lymph. Consequently, viral immunomodulation also occurs when
a virus changes the function or number of lymphoid and myeloid
cells by directly infecting these cell types.
Viruses that cause transient disease, such as measles virus,
sometimes persist for a prolonged period in a subset of individ-
uals (Griffin et al., 2012). It is also common to be infected by
related viruses multiple times over the course of a lifetime, as
observed with respiratory viral infections. For these reasons, it
might be useful to consider viruses that are better known for
causing acute disease as part of the virome, although the long-
term immunomodulatory consequences of chronic viral infec-
tions are more obvious.
Deleterious Consequences of Viral Immunomodulation
The immune response to a virus sometimes resolves the infec-
tion with modest discomfort, as in the case of the common
cold. In other instances, immune effectors cause substantial
collateral damage in the form of tissue destruction, scarring,
and organ failure. For chronic infections, the failure to completely
remove the virus might lead to disease downstream of sus-
tained immunopotentiation, as exemplified by liver fibrosis and
cirrhosis caused by CTLs recognizing a continuous source of
HCV and HBV antigens (Guidotti and Chisari, 2006). Infection
can also promote immunosuppression that facilitates secondary
infection. Depletion of CD4+ T cells by HIV is a striking example
of the catastrophic effects of viral immunosuppression (Maart-
ens et al., 2014). Cancer is another deleterious consequence of
viral immunomodulation. In addition to disrupting the integrity
of the host genome or contributing oncogenes, as seen in human
papillomavirus (HPV) infections that lead to cervical cancer
(Frazer et al., 2011), viral infections promote tumorigenesis by
altering the environment. Hepatocellular carcinoma is a down-
stream complication of HCV and HBV infection (Guidotti and
Chisari, 2006). Also, Kaposi’s sarcoma herpesvirus (KSHV)
encodes several homologs of host proteins involved in immunity,
such as viral IL-6 (vIL-6) and Fas-associated death domain-like
IL-1-converting enzyme inhibitory protein (vFLIP), which stimu-
late angiogenesis and NF-kB signaling to create conditions
that are favorable to the sarcoma and lymphomas associated
with this virus (Ganem, 2010).
Given the diversity of viruses and the reactions they evoke
from the host, it is likely that viral immunomodulation is a contrib-
uting factor for many of the complex inflammatory diseases that
have an unknown etiology. For instance, lymphocytes reactive to
Epstein-Barr virus (EBV) are enriched in affected tissue and
serum from patients presenting several autoimmune diseases,
including systemic lupus erythematosus (SLE), rheumatoid
arthritis, Sjogren’s syndrome, and multiple sclerosis (Draborg
et al., 2013; Mu¨nz et al., 2009). The mechanism of these associ-
ations could involve cross-reactivity toward self-antigens by
lymphocytes that were selected based on recognition of a viral
antigen (molecular mimicry) or an adjuvant effect of the virus
whereby the infection alters the environment (bystander activa-
tion) (Mu¨nz et al., 2009). This link between EBV and autoimmunity
is controversial because of the ubiquitous presence of this
herpesvirus in the healthy population and the difficulty in
providing definitive evidence. Nevertheless, animal models
support a role for molecular mimicry and bystander activation
AB
Figure 2. Types of Virome Interactions
The virome exists within the microbiome network
and interacts with the bacterial microbiome and
other organisms that inhabit the host such as
fungi (mycobiome), archaea, protozoans, and
helminths. The effect of the virome on the host
genome represents a subset of the host genome-
microbiome interaction. A simple relationship
between the virome and host genome is the
virus-plus-susceptibility-gene interaction, where a
phenotypic outcome, such as a disease pathology
or symptom, is evoked by the combination of
a viral infection and host gene variant (a-i). In
addition to this synthetic interaction, another
type of virus-plus-susceptibility-gene interaction
is phenotypic complementation, in which the viral
infection masks the effect of a host gene variant
(a-ii). Although examples are lacking, a virus could
induce benefits in a manner dependent on a host
gene variant, or negate the beneficial effect of a
gene variant. In situations where the outcome is a
complex disease or trait, the virome-genome
interaction involves multiple viruses and host
genetic variants (b). Some genetic variants exist in
non-coding region and might influence gene
expression in a manner dependent on viral infec-
tion. These interactions are influenced by other
members of the microbiome, which regulate the
activities of both the host and the virus.
Immunity
Reviewas mechanisms by which autoimmunity arises downstream of
immunomodulation by EBV or other viruses (Mu¨nz et al., 2009).
Genetic risk factors are insufficient to explain the origin of
many inflammatory diseases, suggesting an essential role for
environmental factors. Crohn’s disease and ulcerative colitis,
the two major types of inflammatory bowel disease (IBD), are
proposed to be the result of an abnormal immune response to
intestinal commensal bacteria (Huttenhower et al., 2014). Many
of the IBD risk alleles occur in regions containing genes that
have known functions in host-microbe interactions, such as
the common T300A polymorphism in the autophagy gene
ATG16L1 associated with Crohn’s disease (Huttenhower et al.,
2014).Micewith decreased expression ofAtg16l1 develop intes-
tinal abnormalities that are observed in Crohn’s disease patients
(Cadwell et al., 2008), but only in the presence of a persistent
strain of MNV (Cadwell et al., 2010). In this model, Atg16l1
mutation is associated with virus-induced inflammatory gene
expression and cytokine activity rather than an increase in viral
burden, implicating immunopotentiation. MNV also exacerbates
intestinal inflammation in IL-10-deficient mice, a commonly used
animal model of IBD (Basic et al., 2014). These observations
demonstrate a virus-plus-susceptibility-gene interaction and
introduce a potential role for an enteric virus in what is widely
considered a disease dependent on intestinal bacteria (Hutten-
hower et al., 2014). If the virome is viewed as part of the micro-
biome instead of a separate entity, then this role for a virus is
consistent with the extensive literature implicating the gut
microbiome in IBD and is not mutually exclusive with a role for
commensal bacteria (Figure 2).
A virus-plus-susceptibility-gene interaction can be highly spe-
cific. The above Atg16l1 mutant mice do not develop intestinal
abnormalities upon infection with a non-persistent strain of
MNV (Cadwell et al., 2010), and the same mice are paradoxically
protected from infection by the model enteric bacterial pathogen
Citrobacter rodentium (Marchiando et al., 2013). Additionally,mice deficient in Nod2, another major Crohn’s disease suscep-
tibility gene, develop intestinal abnormalities due to immuno-
modulation by an ubiquitous intestinal bacterium Bacteroides
vulgatus rather than MNV (Ramanan et al., 2014). Although it is
unclear which specific members of the microbiome contribute
to IBD in humans, it is possible that the exact offending infectious
agent is dependent on the genotype of the patient, and in some
cases, it might be a viral member of themicrobiome rather than a
bacterium that has the strongest role.
The virus-plus-susceptibility-gene interaction paradigm is the
simplified version of the virome-genome interaction (Foxman
and Iwasaki, 2011), where multiple viruses and alleles in the
host genome dictate disease course in a combinatorial manner
(Figure 2). In both humans and rodent models, a constellation
of genetic and environmental factors including MHC haplotype
promote the development of type 1 diabetes (T1D) (Concannon
et al., 2009; Ghosh et al., 1993). A considerable number of epide-
miological studies suggest that enteroviruses are one of the
environmental susceptibility factors (Tauriainen et al., 2011). In
support of a causal role, the enterovirus coxsackievirus B
isolated from the pancreatic tissue of a diabetic child has been
demonstrated to cause pancreatic islet b-cell death and dia-
betes in mice (Notkins et al., 1979). A virus does not necessarily
have to infect the pancreas to trigger diabetes. Infection by
rotavirus, a major cause of gastroenteritis in children, is associ-
ated with a concurrent increase in autoantibodies in children
genetically at risk for T1D (Honeyman et al., 2000). In non-obese
diabetic (NOD) mice with pre-existing autoimmunity, rhesus
monkey rotavirus (RRV) accelerates diabetes by infecting lymph
nodes and not the pancreas (Graham et al., 2008; Pane et al.,
2013). This long-range immunopotentiation is probably medi-
ated by IFN-I, which when produced by lymph node plasmacy-
toid dendritic cells that take up RRV, induces the activation of
uninfected bystander dendritic cells, B cells, and autoreactive
T cells (Pane et al., 2014). Consistent with this mechanism,Immunity 42, May 19, 2015 ª2015 Elsevier Inc. 807
Figure 3. Relationship between Murine
Norovirus and Commensal Bacteria
The enteric positive-strand RNA virus murine
norovirus (MNV) displays similarities with com-
mensal bacteria including the ability to establish
long-term co-existence with the host without
causing disease, to promote development of
the intestine and associated immune system,
to protect against chemical and infectious dam-
age to the intestine, and to cause pathologies
resembling inflammatory bowel disease (IBD) in
genetically susceptible hosts (virus-plus-suscep-
tibility-gene interaction). MNV also interacts with
commensal bacteria, much like bacteria interact
with one another. Examples of these interactions
include the role of bacteria in promoting MNV
persistence through blocking interferon-l (IFN-l)
activity, the dependence of MNV on bacteria for
binding and infecting cells, the ability of MNV to
alter the relative abundance of bacterial pop-
ulations, and immunopotentiation by MNV result-
ing in increased susceptibility to bacteria that
enter circulation. Additionally, MNV exacerbates
the intestinal injury response in the genetically
susceptible host in a manner dependent on
bacteria. This observation provides an example in
which MNV interacts with the host together with
commensal bacteria.
Immunity
Reviewmutations that inhibit IFN-I production by the viral RNA sensor
IFIH1 (MDA5) protect against T1D development in humans
(Nejentsev et al., 2009; Shigemoto et al., 2009).
Viruses that commonly infect infants and children are impli-
cated in chronic lung disease. Severe lung infection by a rhino-
virus in the first couple years of life has a strong correlation
with development of asthma, and similar to T1D, susceptibility
genes include those involved in viral recognition such as toll-
like receptor 7 (TLR7) and TLR9 (Bartlett et al., 2009; Foxman
and Iwasaki, 2011). Rhinovirus and Sendaivirus infections sensi-
tize mice to airway inflammation resembling aspects of human
asthma and chronic obstructive pulmonary disease (COPD)
(Bartlett et al., 2008; Kim et al., 2008). All together, there is sub-
stantial evidence implicating the virome in a variety of chronic
inflammatory diseases.
Many genetic variants associated with disease susceptibility
occur in non-coding regions (Maurano et al., 2012). Systems
biology approaches examining monocytes and dendritic cells
indicate that common genetic variants affect the expression of
hundreds of immune-related genes in a manner dependent on
exposure to LPS, IFN-g, influenza virus, or IFN-b (Fairfax et al.,
2014; Lee et al., 2014). These findings suggest that genetic
variants might be responsible for inter-individual differences in
the transcriptional response to infectious stimuli including the
virome.
Beneficial Effects of Viral Immunomodulation
Plant and insect viruses are known to confer key benefits to their
hosts including protection from harsh weather conditions and
pathogens (Roossinck, 2011). Experiments in mouse models
indicate that viral immunomodulation is another way in which
animal viruses benefit the host. Although viruses can accelerate
pre-existing autoimmune diabetes, infecting young NOD mice
with LCMV prevents disease through immunosuppression (Old-
stone, 1988). Similarly, the g-herpesvirus 68 (gHV68), a model
for EBV and KSHV, protects against SLE-like disease (Larson808 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.et al., 2012). In contrast to this immunosuppressive activity,
gHV68 confers protection against secondary infection by Listeria
monocytogenes and Yersinia pestis by sustaining IFN-g produc-
tion and macrophage activation (Barton et al., 2007). Through a
relatedmechanism, gHV68 infection reverses immunodeficiency
in mice lacking the linear ubiquitin chain assembly complex
(LUBAC) protein HOIL-1 (MacDuff et al., 2015), which is mutated
in patients that display a spectrum of abnormalities including
susceptibility to bacterial infections (Boisson et al., 2012).
Thus, virus-plus-susceptibility-gene interaction can lead to a
beneficial phenotypic complementation (Figure 2), and differ-
ences in the virome could partly explain how patients with Men-
delian disorders can display different symptoms.
The concept that the virome is a subset of the microbiome is
strengthened by the observation that MNV can replace many
of the benefits provided by commensal bacteria in the intestine
(Kernbauer et al., 2014). Germ-free mice and antibiotics-treated
mice display developmental abnormalities in the intestine and
associatedmucosal immune systemdue to the absence of intes-
tinal bacteria that provide important stimulatory signals (Hooper
and Gordon, 2001). MNV infection of these mice that lack bacte-
ria reverses these abnormalities and protects against intestinal
injury caused by chemical insult or bacterial infection (Kernbauer
et al., 2014). Therefore, this model intestinal virus displays many
similarities with commensal bacteria such as those belonging to
theBacteroides genus—MNV can be a lifelong companion of the
host, is typically innocuous but causes disease in geneticmodels
of IBD, stimulates lymphoid differentiation, and is beneficial
under certain conditions (Figure 3). As discussed below, another
way in which MNV resembles commensal bacteria is that it inter-
acts with other members of the gut microbiome.
Although virally induced IFN-I has been suggested to be detri-
mental in autoimmunity, the beneficial effects ofMNV are depen-
dent on the IFN-a receptor (Ifnar) (Kernbauer et al., 2014). In
another example, the b-herpesvirus murine cytomegalovirus
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phage production of Apolipoprotein L9 molecules that stimulate
epithelial proliferation in multiple organs (Sun et al., 2015).
Although many of the IFN-stimulated genes (ISGs) induced by
IFN-I signaling have known antiviral activity, a considerable
number of them are poorly characterized. Examining the function
of these genes and the intersection between IFN-I and other
cytokines will be an important step toward elucidating mecha-
nisms of viral immunomodulation.
Human noroviruses are unlikely to provide any benefits during
the typical course of infection in which they are eliminated rapidly
by the immune system after causing acute gastroenteritis. How-
ever, prolonged shedding of noroviruses has been detected in
both immunocompromised and immunocompetent individuals,
which has been suggested to contribute to the spread of the
virus (Karst et al., 2014). Based on observations with MNV, it
would also be important to consider immunomodulatory con-
sequences of an extended asymptomatic infection. The effect
of other enteric viruses detected in asymptomatic individuals
has received even less attention. These questions have practical
implications because viruses can be transferred during fecal
transplantation procedures, which is used to treat Clostridium
difficile colitis and being considered for other disorders (Pamer,
2014). Potential deleterious or beneficial consequences of trans-
ferring the virome require further investigation.
Immunomodulation by Endogenous Viral Elements and
Phages
Although not the focus of this review, it is important to acknowl-
edge the contribution of other members of the virome. Endoge-
nous retroviruses (ERVs), the most common endogenous viral
element, have had a major impact on mammalian evolution
(Feschotte and Gilbert, 2012) and continue to affect our biology
including immunity. For instance, when T-cell-independent
antigens bind the B cell receptor (BCR), ERV RNA expression
is induced, which triggers antiviral signaling that is necessary
for IgM production (Zeng et al., 2014).
Bacterial, archaeal, fungal, and protozoan members of the
microbiome are subject to infection by viruses, which constitute
a substantive part of the mammalian virome (Zhang et al., 2006).
Out of these, phages in the intestine have received the most
attention in the context of themicrobiome and immunity. Phages
affect the mammalian host by killing susceptible pathogenic or
commensal bacteria and mediate the exchange of virulence fac-
tors between bacteria through horizontal gene transfer (Duerkop
and Hooper, 2013). Phages are enriched in themucus overlaying
the intestinal epithelium and are therefore in a position to provide
an additional layer of defense to protect the barrier (Barr et al.,
2013). Also, the mammalian immune system is capable of
directly responding to large quantities of phages, but the physi-
ological setting in which this occurs remains unknown (Duerkop
and Hooper, 2013).
Much like bacterial dysbiosis, a term that refers to an imbal-
ance in the composition of the microbiome, ‘‘viral dysbiosis’’
could be a marker of mucosal inflammation. IBD patients show
an increase in richness (increase in taxa) of intestinal phages,
especially members belonging to the Caudovirales order of
double-stranded DNA phages (Norman et al., 2015). The lung
virome (including both phages and animal viruses) is altered in
individuals with cystic fibrosis (Willner et al., 2009). A deeperunderstanding of how phages interact directly or indirectly with
the mammalian host will help determine whether altered phage
content contributes to inflammatory disease.
Relationship between Animal Viruses and Commensal
Bacteria
Enteric viruses evolved in the presence of bacteria and require
their presence for efficient replication and transmission. Bacte-
rial LPS and peptidoglycan stabilize the poliovirus virion and
facilitate attachment to host cells (Kuss et al., 2011; Robinson
et al., 2014). IL-10 is produced when TLR4 is activated bymouse
mammary tumor virus (MMTV) bound to LPS, which mediates
the immunosuppression necessary for viral transmission (Kane
et al., 2011). Mice deficient in commensal bacteria also display
reductions in reovirus pathogenicity and MNV replication
(Figure 3; Baldridge et al., 2015; Jones et al., 2014; Kernbauer
et al., 2014; Kuss et al., 2011). Consistent with these obser-
vations, the widely circulating GII.4 human norovirus strain
infects cultured B cells, but only in the presence of commensal
bacteria. Certain bacteria, such as Enterobacter cloacae, have
surface glycoproteins homologous to histo-blood group anti-
gens (HBGAs) that bind the virion to mediate attachment to
host cells (Jones et al., 2014). Also, the bacterial microbiome
promotes persistent infection of MNV through modulation of
the antiviral activity of another IFN cytokine family member,
IFN-l (IFN-III) (Figure 3; Baldridge et al., 2015). Remarkably,
IFN-l is sufficient for sterilizing immunity to MNV (Nice et al.,
2015).
Commensal bacteria can enhance host immunity to viruses.
Altering the composition of gut bacteria with antibiotics de-
creases the CD4+ T cell, CD8+ T cell, and antibody responses
to influenza lung infection by interfering with innate immune
signals that act on migrating dendritic cells (Ichinohe et al.,
2011). In another example, flagellin from commensal bacteria
in the intestine act as an adjuvant that stimulates TLR5 and
induces plasma cells to generate antibodies in response to
inactivated influenza and polio vaccines (Oh et al., 2014). Activa-
tion of TLR5 with flagellin also prevents rotavirus infection and
eliminates the virus from persistently infected mice by inducing
an innate immune response through IL-22 and IL-18 (Zhang
et al., 2014). A key future direction is to determine whether these
mechanisms represent therapeutic targets for treating chronic
viral infections in humans.
Viral immunomodulation can disrupt the balanced co-exis-
tence between the host and the bacterial microbiome. Mucosal
T cell depletion by HIV and SIV infection leads to translocation of
commensal bacteria through the intestinal epithelium, which
fuels chronic inflammation and disease progression (Brenchley
et al., 2006). MNV potentiates the inflammatory properties of
otherwise innocuous bacteria in several situations (Figure 3). In
the Atg16l1mutant mouse model, MNV causes IBD pathologies
after intestinal injury in a manner dependent on commensal
bacteria (Cadwell et al., 2010). Also, IFN-I induction by MNV
leads to a lethal response to E. coli in a model of sepsis by
increasing pro-inflammatory signaling through the bacterial
sensors Nod1 and Nod2 (Kim et al., 2011b). Additionally, infec-
tion by an acute strain of MNV or human norovirus alters the
composition of the bacterial microbiome (Hickman et al., 2014;
Nelson et al., 2012). Given the proposed role of commensalImmunity 42, May 19, 2015 ª2015 Elsevier Inc. 809
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be important to determine whether transient or chronic infection
by animal viruses cause long-lasting changes to the bacterial
microbiome.
Viruses Interact with Helminths and Protozoans
Mammals have also co-evolved to tolerate the presence of
helminth infections, which remains widespread among people
living in developing countries. Infection of mice by Schistosoma
mansoni and Heligmosomoides polygyrus induces the Th2
cytokine IL-4 that signals through the transcription factor
Stat6, which specifically binds the gHV68 genome to reactivate
the virus from latency (Reese et al., 2014). The ability to reacti-
vate in the presence of IL-4 is conserved in KSHV, providing
key evidence that viruses have adapted to the presence of
helminths. Co-infection with MNV and the intestinal nematode
Trichenella spiralis diminishes the numbers and effector func-
tions of virus-specific CD4+ and CD8+ T cells (Osborne et al.,
2014). This inhibitory effect of the helminth is independent
of commensal bacteria. Instead, T cell suppression is mediated
by the chitinase-like molecule YM1 produced by alternatively
activated macrophages (AAMs) that are part of the Th2 cell
response to T. spiralis (Osborne et al., 2014).
Although individuals living in industrialized nations today are
less likely to be infected by helminths, therapeutic modalities
involving helminths or their products are being considered for
inflammatory diseases (Wolff et al., 2012). The effect of helminths
on viruses needs to be consideredwhen applying these interven-
tion strategies. Additionally, the malarial parasite Plasmodium
falciparum causesmultiplemolecular changes in germinal center
B cells latently infected by EBV, which could explain why Bur-
kitt’s lymphoma is common in young children in tropical Africa
(Torgbor et al., 2014). Understanding howprotozoan and helmin-
thic parasites affect the virome will continue to be relevant.
Intra-virome Interactions
Just as bacteria communicate with each other within the micro-
biome ecosystem, inter-virus interactions within the virome have
been documented. EBV infection expands the pool of memory
CD8+ T cells that cross-react with antigens from other viruses
such as influenza (Clute et al., 2005). Through a mechanism
that resembles molecular mimicry in autoimmune disease, this
cross-reactivity is associated with the pathological proliferation
of activated CD8+ T cells during infectious mononucleosis. The
presence of such cross-reactive lymphocytes as well as other
forms of viral immunomodulation have an immense influence
on heterologous immunity to subsequent viral infections that
can be either desired or unfavorable during vaccination (Selin
et al., 2006). Viral infection can also alter the innate immune
response to a second virus. Persistent LCMV infection reduces
IFN-I production by plasmacytoid DCs and impairs the NK cell
response to MCMV (Zuniga et al., 2008). EBV infection induces
transcription of a superantigen encoded by the env gene of
ERV-K18, leading to polyclonal T cell proliferation, providing an
interesting example in which an ERV mediates immunomodula-
tion by an exogenous virus (Stauffer et al., 2001).
The restructuring of the immune system by HIV and SIV has
profound effects on the activity of other viruses. KSHV causes
Kaposi’s sarcoma in only a small percentage of immunocompe-810 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.tent individuals, but the incidence of this viral cancer is high
in patients with AIDS and reversed by antiretroviral therapy (Ga-
nem, 2010). AIDS caused by SIV infection leads to a substantial
expansion of the enteric virome with the appearance of dozens
of previously unknown animal viruses, indicating that primates
harbor many intestinal viruses that are normally kept in check
by the immune system (Handley et al., 2012). Similarly, an altered
plasma virome, including an increase in anelloviruses and ERVs,
is observed during human AIDS (Li et al., 2013). Together with
commensal bacteria in the gut, these commensal viruses could
have a pathological role in the chronic inflammation associated
with disease progression. In contrast, some viruses are associ-
ated with slower HIV disease progression. The presence of GB
virus C, a Flavivirus that can persist in immunocompromised
individuals, significantly improves the outcome of HIV infection
(Tillmann et al., 2001; Xiang et al., 2001). Also, the Fv1 gene
derived from the gag-region of an ERV confers resistance to
murine leukemia virus (MLV) by binding the viral capsid (Best
et al., 1996).
In addition to protecting against bacterial disease (Barton
et al., 2007), herpesvirus infection is associated with improved
antiviral immunity. A recent study found that young adults
who are seropositive for human cytomegalovirus (HCMV) have
elevated concentrations of circulating IFN-g and other signs of
increased antiviral immunity and displayed a superior antibody
response to influenza vaccination (Furman et al., 2015). In this
same study, MCMV infection of mice was found to reduce
influenza virus replication and enhance the CD8 T cell response
to influenza antigens, thereby validating the data obtained in
humans. Better resolution of the human virome along with com-
plementary functional studies in animal models will probably
reveal many other synergistic and antagonistic relationships
between viruses.
Toward a Holistic View of the Virome
Virology will continue to serve as an essential discipline that ex-
amines life-threatening pathogens. Nevertheless, the incredible
progress in characterizing virus-host interactions highlighted
in this article indicates that the virome is more than a collec-
tion of pathogens and includes viruses that function much like
symbiotic bacteria. One key lesson from these studies has
been that one virus could have multiple adverse and beneficial
immunodulatory effects on the host that are dependent on the
anatomical location, host genotype, and the presence of other
infectious agents and commensal microbes (Figure 3). It is often
the context that determines whether a virus is deleterious,
neutral, or beneficial to the host. Although viruses are technically
not organisms because they require the cellular machinery to
replicate, it is helpful to view them as members of the microbial
network that contributes to the host phenotype.
Another theme revealed by the literature discussed in this
review is that the virome adds to the gene content and
coding potential of the host (Figure 2). In the case of ERVs, the
viral genome is literally part of the host genome. Retroviruses
integrate into the host DNA and are part of the genome in in-
fected cells. Herpesvirus and papillomavirus episomes that are
attached to the host chromosome might not be too different
in this sense, and some viruses that replicate outside the nucleus
can contribute RNA and protein over long periods of time. Thus,
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Reviewvirus-plus-susceptibility-gene interactions and virome-genome
interactions are expected outcomes of this co-existence. In
some cases, a virus will evoke the effect of a genetic variant
in the host in a manner analogous to synthetic lethality (MNV +
Atg16l1 mutation), where two mutations are necessary to
yield a result. In other instances, a virus will mask the effect of
a genetic variant (gHV68 + HOIL mutation), similar to genetic
complementation.
There is little known about many of the viruses that inhabit us
(many of which are yet to be discovered) because the research
emphasis has been on viruses that cause obvious disease.
With all the remaining questions surrounding human physiology
and why certain individuals develop a given disease, can we
afford to ignore these viruses? Examination of cell populations,
serum proteins, and response to cytokine stimulation in sam-
ples collected from twins indicates that variation in the human
immune response is largely driven by non-heritable factors
(Brodin et al., 2015). Many of the inflammatory diseases in
question are associated with industrialization or geography,
and thus a changing virome could be one of the factors
involved. A particular virus does not have to be the culprit in
every incidence of the disease to be an important variable.
For certain complex diseases like IBD, there might be multiple
routes toward developing pathology, and a virus might be one
of many contributing factors.
If viruses sway disease susceptibility in such a manner, then
the following represent important goals of future virology.
(1) Cataloging the mammalian virome. Exposing associations
between viruses and host traits requires knowing the diversity
and prevalence of viruses that are present in the host. The tech-
nological hurdles are not trivial, but identification of viruses by
deep sequencing is becoming more feasible due to decreasing
costs and improvements in the bioinformatics pipelines.
(2) Establishing advanced in vitro infectionmodels. Innovations
in cell culture that mimic in vivo conditions such as organoids
and 3D cultures will allow investigation of viruses that are other-
wise difficult to examine. Once established, leukocytes and
commensal bacteria can be added to these cultures to recreate
multicellular and polymicrobial interactions.
(3) Identifying novel properties of viruses in animal models. An-
imal models and model viruses such as LCMV and MNV will
continue to reveal unappreciated effects of viral immunomodula-
tion and transkingdom interactions that are apparent only in an
intact organism.
(4) Including measurements of viruses in systems-level ana-
lyses. Quantification of multiple parameters in a well-defined
human cohort can be used to identify complex interactions
between genetic and environmental variables. When the host,
virus, and other members of the microbiome are examined
together, a more complete picture of mammalian biology will
emerge.
It is important not to lose sight of the fact that the virome
includesmany serious pathogens. Generating effective antivirals
and vaccines will remain a research priority for many years to
come, and evidence that viral infection has beneficial effects
should not be used to interfere with these efforts. Instead, we
should strive to understand the pathways and factors that
determine whether a virus has a deleterious or advantageous
impact on the host. This advanced understanding will assist inthe design of therapies based on immunomodulation that can
be applied to both viral and non-viral diseases.
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